TET2 and neoplasm: Furthermore, mouse studies have shown that TET2 reshapes chromatin accessibility at genomic binding regions of key transcription factors involved in immune signaling (e.g., BATF and ETS1) favoring disfunction of tumor infiltrating lymphocytes (TIL) (Lee et al., 2021).